Pegah Tavakolzadeh

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Randomized Controlled Trial

Systematic Review

Depressive Symptoms

Atopic Dermatitis

Top Venues

Inflammopharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Mohammad Ali Nilforooshzadeh, Nazila Heidari, Yekta Ghane, Amirhossein Heidari, Arman Hajikarim-Hamedani, Seyedayin Hosseini, Fariba Jaffary, Minou Najar Nobari, Pegah Tavakolzadeh, Niloufar Najar Nobari
A systematic review of interleukin-31 inhibitors in the treatment of prurigo nodularis. Inflammopharmacology 32 (2) (2024)
Mohammad Ali Nilforooshzadeh, Nazila Heidari, Yekta Ghane, Amirhossein Heidari, Arman Hajikarim-Hamedani, Seyedayin Hosseini, Fariba Jaffary, Minou Najar Nobari, Pegah Tavakolzadeh, Niloufar Najar Nobari
A systematic review of interleukin-31 inhibitors in the treatment of prurigo nodularis. Inflammopharmacology (2024)
Mohammad Ali Nilforooshzadeh, Nazila Heidari, Yekta Ghane, Amirhossein Heidari, Arman Hajikarim-Hamedani, Seyedayin Hosseini, Fariba Jaffary, Minou Najar Nobari, Pegah Tavakolzadeh, Niloufar Najar Nobari
A systematic review of interleukin-31 inhibitors in the treatment of prurigo nodularis. Inflammopharmacology 32 (2) (2024)
Mohammad Ali Nilforooshzadeh, Nazila Heidari, Yekta Ghane, Amirhossein Heidari, Arman Hajikarim-Hamedani, Seyedayin Hosseini, Fariba Jaffary, Minou Najar Nobari, Pegah Tavakolzadeh, Niloufar Najar Nobari
A systematic review of interleukin-31 inhibitors in the treatment of prurigo nodularis. Inflammopharmacology 32 (2) (2024)
Mohammad Ali Nilforooshzadeh, Nazila Heidari, Yekta Ghane, Amirhossein Heidari, Arman Hajikarim-Hamedani, Seyedayin Hosseini, Fariba Jaffary, Minou Najar Nobari, Pegah Tavakolzadeh, Niloufar Najar Nobari
A systematic review of interleukin-31 inhibitors in the treatment of prurigo nodularis. Inflammopharmacology 32 (2) (2024)